The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Olive oil grower and producer Cobram Estate Olives (CBO) has completed its first full day of trading after listing on the ASX
  • The Australian business listed on the stock exchange on Wednesday, August 11, under the ticker code CBO
  • Cobram released a number of business updates ahead of its listing, including an explanation of its olive trees’ biennial fruit bearing cycles
  • COB argues its results should therefore be considered over a two-year period, as its profits are often recorded in a year of production and not sales
  • Shares in Cobram Estate Olives are trading up 5.65 per cent at $1.97 per share at 2:18 pm AEST in a $720.6 million market cap

Olive oil grower and producer Cobram Estate Olives (CBO) has completed its first full day of trading after listing on the ASX.

The Australian food business listed on the stock exchange on Wednesday, August 11, under the ticker code CBO.

Since listing, Cobram has released a number of business updates including an explanation of its olive trees’ biennial fruit bearing cycles.

Chair Rob McGavin said in a statement that its trees produced large volumes only every second year.

“Olive trees naturally bear fruit in biennial cycles, with a higher yielding crop one year typically followed by a lower yielding crop in the next year,” Mr McGavin said.

As a result, the Cobram Chair explained the company’s profits were often recorded in a year of production and not sales.

“Under the relevant accounting standards, the profit for each year of harvest is adjusted by the difference between the cost of production and the net realisable value of the oil produced in that year,” Mr McGavin said.

“This means that profit is recorded in the year of production, rather than the year of sale.”

CBO has opened its second day of trading on Thursday at $1.90 per share.

Share were up 5.91 per cent at $1.97 per share at 2:18 pm AEST at in a $720.6 million market cap.

cbo by the numbers
More From The Market Online

Sigma confirms preliminary talks over potential $14B Boots acquisition

Sigma Healthcare is in early discussions to potentially acquire UK pharmacy giant Boots, a deal reportedly…
Lawsuit market concept

Optimism around Guzman Y Gomez’s US exit falters as company hit by class action

When Guzman Y Gomez (ASX:GYG) late last week announced it was exiting the U.S.
Exit sign

“Underperforming our expectations”: GYG ditches the US, and shares jump +15%

If you’re looking for evidence of shareholder confidence on Friday, look no further than the price action for
Piercing

At least it’s not Adultshop: SkinKandy, a piercing store, hits the ASX with plan to go global

In the excitement caused by NVIDIA earnings, renewed Iran war peace hopes and hotter-than-expected unemployment down under, you could be forgiven for overlooking